Equillium, Inc. (EQ)
EQ Stock Price Chart
Explore Equillium, Inc. interactive price chart. Choose custom timeframes to analyze EQ price movements and trends.
EQ Company Profile
Discover essential business fundamentals and corporate details for Equillium, Inc. (EQ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Oct 2018
Employees
35.00
Website
https://equilliumbio.comCEO
Bruce D. Steel
Description
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.
EQ Financial Timeline
Browse a chronological timeline of Equillium, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.05.
Earnings released on 13 May 2026
EPS came in at -$0.06 falling short of the estimated -$0.04 by -50.00%.
Earnings released on 25 Mar 2026
EPS came in at -$0.04 surpassing the estimated -$0.07 by +42.86%.
Earnings released on 13 Nov 2025
EPS came in at -$0.06 surpassing the estimated -$0.14 by +57.14%.
Earnings released on 14 Aug 2025
EPS came in at -$0.16 falling short of the estimated -$0.14 by -14.29%.
Earnings released on 14 May 2025
EPS came in at -$0.24 falling short of the estimated -$0.23 by -4.35%.
Earnings released on 27 Mar 2025
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $4.39m .
Earnings released on 13 Nov 2024
EPS came in at -$0.00 surpassing the estimated -$0.26 by +99.92%, while revenue for the quarter reached $12.16m , beating expectations by +5.29%.
Earnings released on 8 Aug 2024
EPS came in at $0.01 surpassing the estimated -$0.15 by +106.67%, while revenue for the quarter reached $13.85m , missing expectations by -35.27%.
Earnings released on 9 May 2024
EPS came in at -$0.08 surpassing the estimated -$0.17 by +52.94%, while revenue for the quarter reached $10.69m , beating expectations by +18.77%.
Earnings released on 25 Mar 2024
EPS came in at -$0.07 surpassing the estimated -$0.17 by +58.82%, while revenue for the quarter reached $9.21m , beating expectations by +15.14%.
Earnings released on 8 Nov 2023
EPS came in at -$0.11 surpassing the estimated -$0.16 by +31.25%, while revenue for the quarter reached $8.87m , beating expectations by +10.88%.
Earnings released on 9 Aug 2023
EPS came in at -$0.10 surpassing the estimated -$0.19 by +47.37%, while revenue for the quarter reached $9.12m , beating expectations by +14.05%.
Earnings released on 11 May 2023
EPS came in at -$0.11 surpassing the estimated -$0.20 by +45.00%, while revenue for the quarter reached $8.88m , beating expectations by +93.02%.
Earnings released on 23 Mar 2023
EPS came in at $0.08 surpassing the estimated $0.02 by +407.61%, while revenue for the quarter reached $15.76m , missing expectations by -58.53%.
Earnings released on 14 Nov 2022
EPS came in at -$0.40 falling short of the estimated -$0.39 by -2.56%.
Earnings released on 15 Aug 2022
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%.
Earnings released on 12 May 2022
EPS came in at -$0.45 falling short of the estimated -$0.36 by -25.00%.
Earnings released on 23 Mar 2022
EPS came in at -$0.36 falling short of the estimated -$0.34 by -5.88%.
Earnings released on 10 Nov 2021
EPS came in at -$0.35 falling short of the estimated -$0.34 by -2.94%.
Earnings released on 10 Aug 2021
EPS came in at -$0.31 matching the estimated -$0.31.
EQ Stock Performance
Access detailed EQ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
